• About us
  • Membership
  • Contact us
  • Wed February 11, 2026

  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

spinal muscular atrophy

Total:2

  • Oral medicine for SMA patients delivered to Iran 2022-08-09 18:47

    Oral medicine for SMA patients delivered to Iran

    TEHRAN – The first shipment of Evrysdi, an oral medication used to treat spinal muscular atrophy (SMA), has been imported to the country, Saeed Azamian, CEO of the SMA Association of Iran, said on Tuesday.

  • FDA imports medicine for SMA patients 2022-08-02 18:57

    FDA imports medicine for SMA patients

    TEHRAN – The first batch of SPINRAZA – a drug special for patients suffering from spinal muscular atrophy (SMA) - has arrived in the country, the Food and Drug Administration director announced on Tuesday.

All Pages

Latest

  • 15267

  • Judiciary chief says convicts involved in the January riots won’t be amnestied

  • Over 140 rioters involved in recent unrest nabbed

  • Transferring uranium outside Iran not on agenda of Oman talks: nuclear chief 

  • Epstein files, war calculations, and the deeper conflict with Iran

  • America is putting a brave face on defeat

  • Iran to unveil its first radar satellite soon

  • FM, military chief brief parliament on nuclear talks, defense capabilities 

  • Trump, Greenland, and the fracturing of globalization

  • Pezeshkian says Oman-mediated talks offer fair solution if US shows respect

  • ‘Pizza,’ power, and the pedophile blueprint

  • Ayatollah Khamenei: Iranians to affirm loyalty to Islamic Republic on Bahman 22

  • 47 years of resistance

  • Egyptian supporters of the Islamic Republic

  • Ivan Illich’s “Tools for Conviviality” published in Persian

Desktop version Mobile version
Top
  • About us
  • Membership
  • Contact us
  • Home
  • Society
  • Economy
  • Politics
  • Sports
  • Culture
  • International
  • Multimedia
  • Tourism

All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.

Developed by: Nastooh Designed by: Pixel Studio